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Objective: Takayasu aortoarteritis (TA) is common in the Southeast Asian and Indian subcontinent re-
gions with a female-to-male ratio of 8:1. Age at diagnosis is < 30 years in 90% of the cases. Because the
disease is common in women of child-bearing age, management of pregnancy in these patients becomes
an important issue. The purpose of this study is to evaluate the maternal and fetal outcomes in preg-
nancies with TA and also to evaluate whether early intervention for renal artery involvement is asso-
ciated with improved outcomes.
Materials and methods: We collected data of 12 patients with 18 pregnancies prospectively from 2006 to
2012. The patients were divided into three groups and their outcomes were noted: (1) without renal
artery involvement; (2) with renal artery involvement without intervention; and (3) with renal artery
involvement for which intervention has been done.
Results: Body mass index of patients was between 18.5 kg/m2 and 23.2 kg/m2. Renal artery involvement
and hypertension were seen in four patients. One patient had percutaneous transluminal balloon an-
gioplasty and another had renal artery stenting. In patients without renal artery involvement, gestational
hypertension was seen in 50%, pre-eclampsia in 10%, abortion in 10%, and intrauterine growth restriction
(IUGR) in 40% of pregnancies. In patients with renal artery involvement without intervention, gestational
hypertension was seen in 90%, pre-eclampsia in 20%, abortion in 60%, preterm in 20%, IUGR in 20%, fetal
demise in 20%, and neonatal death in 20% of pregnancies. In patients with renal artery involvement for
which intervention has been carried out, gestational hypertension was seen in 66%, and abortion and
IUGR were seen in 33% of pregnancies.
Conclusion: Patients with renovascular involvement without intervention are at high risk of having
maternal and fetal complications. Early intervention prior to conception in these women is recom-
mended to prevent pregnancy complications.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Takayasu aortoarteritis (TA) is panarteritis of the aorta, great
vessels, and renal and pulmonary arteries. The arterial lesions can
lead to secondary hypertension, retinopathy, cardiac involvement,
cerebrovascular events, and premature death [1]. The prevalence of
TA is reported to be in the range of 2.6e6/million in the generalny, Gorakhnath, Gorakhpur,
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bstetrics & Gynecology. Publishedpopulation, and is common in the Southeast Asian and Indian
subcontinent regions with a female-to-male ratio of 8:1. Age at
diagnosis is < 30 years in 90% of the cases [2]. Because the disease is
common in women of child-bearing age, management of preg-
nancy in these patients becomes an important issue. The disease is
characterized by an early inﬂammatory phase, which is associated
with nonspeciﬁc signs and symptoms such as fever, arthralgias, and
weight loss, and a late occlusive or pulseless stage. Compared with
the Western population with TA, where aortic arch involvement is
common, the Asians have more common involvement of the
abdominal aorta and renal arteries. There is paucity of data on
pregnant womenwith Takayasu disease in Western literature. Onlyby Elsevier Taiwan LLC. All rights reserved.
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[3e10]. The course of disease seems to be neither affected nor
worsened by pregnancy unlike other autoimmune disorders. Many
authors have reported adverse maternal and fetal outcomes during
pregnancy but the outcome appears to be goodwith uncomplicated
Takayasu arteritis. The outcome mainly depends on the maternal
vascular involvement, severity of hypertension during pregnancy,
presence of superimposed pre-eclampsia, and early institution of
proper management. The optimal management for pregnant pa-
tients with TA is not yet deﬁned due to the rarity of this condition.
We herein present a series of pregnant patients with Takayasu
arteritis who presented to us during the period between 2006 and
2012. We tried to correlate the disease severity and renal artery
involvement with maternal and fetal complications.Materials and methods
Study design and selection of patients
This was a prospective observational study. Being attached to a
large cardiology referral center, TA is not an uncommon disease at
our center. We started collecting data of this otherwise rare disease
and performed analysis of prospectively collected data from 2007
to 2012 at a tertiary care hospital in Northern India. The patients
were diagnosed on the basis of American College of Rheumatology
Criteria, 1990, and supported by arterial Doppler ﬁndings. The
criteria are as follows: age of disease onset <40 years, claudication
of extremities, decreased brachial artery pulse, blood pressure
difference of >10 mmHg, bruit over the subclavian arteries or aorta,
and angiogram abnormality. Diagnosis of Takayasu arteritis re-
quires that at least three of the six aforementioned criteria are met.
We herein report the course and outcome of 18 pregnancies in 12
patients with Takayasu arteritis. Most patients (83%) were diag-
nosed with Takayasu arteritis prior to pregnancy. None of the pa-
tients was receiving any medical treatment for the disease
remission. All the patients had spontaneous conception without
any assisted reproductive technique. None of the patients under-
went proper preconceptional counseling. Themode of presentation
in these patients is shown in Figure 1.
The patients were classiﬁed according to Ishikawa's criteria into
three groups (Groups IeIII). Group I included patients without
complications. Group II had one of the following complications:
retinopathy, secondary hypertension, aortic regurgitation, andFigure 1. Mode of presentation in patients (n ¼ 12). DCMP ¼arterial aneurysm; this group was subclassiﬁed into Class IIA and
Class IIB according to the severity of each complication. Group III
had two or more of the aforementioned complications. Two thirds
of the patients in our series belonged to Ishikawa Group I, one
fourth of patients belonged to Group II, and one twelfth belonged to
Group III. The fetal and maternal complications in the three Ishi-
kawa groups are mentioned in Table 1.
Doppler imaging of major vessels including renal vessels was
performed in all the patients. Vascular involvement is shown in
Figure 2. Renal artery involvement was seen in four patients. We
observed that patients with renal artery involvement without any
intervention had worst pregnancy outcomes. The pregnancy
outcome in patients with and without renal artery involvement is
discussed in the next section and summarized in Table 2.Results
Patients without renal artery involvement
Eight patients with 10 pregnancies are reported in this group.
The mean age of diagnosis of patients was 20 years. Body mass
index of patients was in range of 18.5e23.2 kg/m2. None of the
patients had hypertension prior to pregnancy. The gestational age
at presentation to us varied between 6 weeks and 24 weeks. Uni-
lateral or bilateral radial pulse was not palpable in any of our pa-
tients except one. Erythrocyte sedimentation rate (ESR) was
elevated in 40% of the patients. Lupus anticoagulant was negative in
all the patients. Blood and urine investigations were normal. Elec-
trocardiogram and echocardiography were normal in all the pa-
tients except for the patient with dilated cardiomyopathy. Her
echocardiography revealed Type III diastolic dysfunction along
with severe systolic dysfunction. There was evidence of mild aortic
and mitral regurgitation and the left ventricular ejection fraction
was 35%. She was started on oral furosemide (40 mg o.d.) and
carvedilol (3.125 mg b.d.). Her Doppler imaging showed abdominal
aorta involvement. The ejection fraction decreased from 35% at 12
weeks of gestation to 20% at 36 weeks of gestation. She was started
on oral digoxin (0.25mg o.d.) alongwith furosemide and carvedilol.
Shewent into spontaneous labor at 39weeks of gestation and had a
ventouse-assisted delivery under epidural analgesia (birth weight
2590 g).
One patient had ﬁrst-trimester missed abortion and was
induced by vaginal misoprostol. Five of ten (50%) pregnancies haddilated cardiomyopathy; LVF ¼ left ventricular failure.
Table 1
Maternal and fetal complications in all the pregnancies (n ¼ 18) divided according to Ishikawa groups.
Complications Group I (n ¼ 9) Group IIa (n ¼ 1) Group IIb (n ¼ 4) Group III (n ¼ 4)
Maternal Gestational hypertension 4 d 1 3
Pre-eclampsia 1 d d 1
Worsening of ejection fraction d d 1 d
Fetal Abortion 1 d 1 3
Intrauterine growth restriction 3 1 1 1
Preterm d d d 1
Intrauterine device d 1 d d
Neonatal intensive care unit admission 1 d d 1
Neonatal death d d d 1
Figure 2. Arterial involvement in patients.
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eclampsia). Four patients required single drug (alpha-methyl-
dopa) and one patient required two drugs (alpha-methyldopa
and labetalol). The patient having pre-eclampsia had fetal growth
restriction and was induced at 39 weeks (birth weight 2300 g).
One patient with a history of second-trimester abortion in pre-
vious pregnancy was given prophylactic low-molecular-weight
heparin (enoxaparin 40 mg subcutaneous o.d.) throughout
pregnancy to improve placental perfusion. She was induced at 39
weeks because of gestational hypertension and delivered vagi-
nally (birth weight 2700 g). Three patients were induced by
cervical prostaglandin E2 gel at 38e39 weeks of gestation due to
hypertension. One patient delivered vaginally (birth weight
2900 g) and two had emergency cesarean section due to failed
induction and fetal bradycardia (birth weight 2800 g and 2600 g,
respectively). Three patients (33.3%) had intrauterine growth
restriction (IUGR) diagnosed at 32e34 weeks of gestation and
labor had to be induced at 37e39 weeks. Two patients delivered
vaginally. Cesarean section was performed in one patient because
of fetal bradycardia, and the baby had to be kept in neonatal
intensive care unit for 3 days due to respiratory distress (birth
weight 2320 g).Table 2
Maternal and fetal complications in patients classiﬁed on the basis of renal artery involv
Complications No renal artery involvem
Maternal Hypertension 5
Pre-eclampsia 1
Fetal Abortion 1
Intrauterine growth restriction 4
Intrauterine device d
Neonatal intensive care unit admission 1
Neonatal death dPatients with renal artery involvement with intervention
Two patients with renal artery involvement had intervention
prior to conception. One had hypertensive crisis leading to left
ventricular failure at the age of 21 years. She was diagnosed as TA
thereafter, and had undergone stenting of the bilateral renal ar-
teries. She required antihypertensives after the procedure. She had
two pregnancies, the ﬁrst being amissed abortion at 8 weeks. In the
second pregnancy, she had hypertension and mild proteinuria. She
was induced at 38 weeks' gestation because of hypertension and
mild IUGR, and delivered vaginally (birth weight 2460 g).
Another patient had percutaneous transluminal balloon angio-
plasty of the left renal artery at the age of 16 years when she had
developed severe uncontrolled hypertension. She remained
normotensive after the intervention. She had a successful preg-
nancy outcome without any hypertension or growth restriction.
She went into spontaneous labor and delivered vaginally at 37
weeks with birth weight of 2800 g.
Patients with renal artery involvement without intervention
Two patients had renal artery involvement and had no prior
intervention for it. ESR was raised in both the patients. The ﬁrst
patient was diagnosed during pregnancy at the age of 21 years due
to hypertension and pulselessness. She had deranged renal func-
tion tests at presentation with blood urea of 96 mg/dL and serum
creatinine of 1.9 mg/dL. She also had gross proteinuria at presen-
tation. Dilated fundus examination showed Grade II hypertensive
retinopathy. Magnetic resonance imaging revealed shrunken
bilateral kidneys (Figure 3). She was on atenolol (50 mg) for blood
pressure control prior to pregnancy. She had four pregnancies
registeredwith us. In three pregnancies, the patient presented to us
with fetal demise at 9 weeks, 10 weeks, and 19 weeks and aborted
spontaneously. In the fourth pregnancy, the patient presented to us
at 6 weeks of gestation. We started her on low-molecular-weight
heparin (enoxaparin 40 mg subcutaneous o.d.) along with antihy-
pertensives. She required four drugs in maximum doses (alpha-
methyldopa, labetalol, nifedipine, and prazosin) for blood pressure
control. Despite all these measures, she had early onset IUGR at 24ement.
ent (n ¼ 10) Renal artery involvement
With intervention (n ¼ 3) Without intervention (n ¼ 5)
2 5
0 1
1 3
1 1
d 1
d 1
d 1
Figure 3. Magnetic resonance imaging reveals shrunken bilateral kidneys.
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imetry. At 29 weeks of gestation, her fetal Dopplers were deranged
with reversal of ﬂow in ductus venosus. We performed an elective
cesarean section at 29 weeks and delivered a baby weighing 900 g.
The neonate was kept in the neonatal intensive care unit but died
on the 25th day due to septicemia.
The secondpatientwith renal artery involvement also had a poor
obstetric outcome. She had renal asymmetry seen on ultrasonog-
raphy; however, other investigations were normal. Magnetic reso-
nance angiography showed renal arterial involvement (Figure 4).
She also had hypertension and early onset IUGR at 26 weeks of
gestation. She was on two drugs for blood pressure control. Unfor-
tunately, she had intrauterine fetal demise at 29 weeks of gestation.
The patient had spontaneous vaginal delivery at 30 weeks.Postnatal follow-up
All of the patients were discharged with contraceptive advice
and postpartum follow-upwas done in all of the patients. The threeFigure 4. Magnetic resonance angiography shows renal arterial involvement.patients with renovascular hypertension required antihyperten-
sives after delivery too. Others did not require any antihyperten-
sive. The patient with dilated cardiomyopathy continued diuretic
and digoxin medications. Both of the patients with renal artery
involvement without intervention were advised to receive renal
artery stenting. The procedure could not be performed in the ﬁrst
patient because both her renal arteries were completely stenosed
and there was a development of collaterals from the intercostal
vessels to the kidneys. Hence, she was planned for angioplasty.
They continue to be under follow-up in the cardiovascular
department for performing interventions. They were also advised
to plan their next conception after these interventions for a better
outcome.
Discussion
There are several case series of pregnancies with TA (Table 3).
Young women in the child-bearing age group are usually affected
by this disease, and therefore, pregnancy management in these
patients is critical. The age group of pregnant patients with TA, as
reported in various studies, ranges between 15 years and 35 years
[3e11]. In our series, the age of patients ranged from 22 years to 28
years. Most patients are diagnosed prior to conception and they
may present with fatigue, myalgia, arthralgia, and low-grade fever
in initial stages and intermittent claudication, visual defects, and
fainting attacks in later stages. Many may be diagnosed after clin-
ical examination, when one or more peripheral pulses are not
palpable or blood pressures vary in two limbs. The classic sign of TA
(i.e., pulselessness) was seen in 91.6% of the patients in our series,
which is almost similar to other studies (range, 85e95%) [1,12].
Patientsmay also present with other dreaded complications such as
myocardial ischemia, accelerated hypertension, pulmonary hyper-
tension, cardiac failure, and dilated cardiomyopathy. One patient
(8.3%) had dilated cardiomyopathy in our case series. It is reported
to be seen in 5.58% of patients with TA in another series [13]. Pre-
pregnancy hypertension was seen in 25% of our patients; other
studies reported it to be varying from 20% to 60% in TA patients
[14,15]. The mean age of onset of symptoms, as reported in a large
case series on TA, is 24.0 ± 8.8 years [1]. Our patients have a mean
age of diagnosis of 20 years. The earlier diagnosis among our pa-
tients may be due to increased health awareness among population
and advances in health care facilities with time. Patients in this
series did not have any element of infertility and all of them had
spontaneous conception. Pregnancy should be planned in disease
remission phase for better outcomes [16]. Preconception coun-
seling is necessary regarding appropriate adjustment of dosage or
cessation of cytotoxic drugs, folic acid supplementation in the
periconceptional period, and optimal timing of pregnancy. The
drugs used in TA are corticosteroids, cytotoxic agents such as
cyclophosphamide and methotrexate, antihypertensive agents,
antiplatelet drugs, anticoagulants, and immunosuppressants such
as azathioprine. None of our patients were on corticosteroids or
cytotoxic agents. ESR was elevated in 50% of our patients, compared
with 45.5% in a large study involving 88 patients [1]. Renal function
test was mildly deranged in one patient (8.3%) and none of the
patients had renal failure, whereas in another study mild renal
function derangement was seen in 1.25% of patients and renal
failure was seen in 4.5% of patients [17]. Proteinuria was seen in
16.7% of patients in our series whereas a prior study reported it in
37.5% of patients [17]. There are also case reports of TAwith positive
lupus anticoagulant test results [18]. Aortic andmitral regurgitation
were seen in one patient in our series, whereas they were found in
40.7% and 25% of patients, respectively, in another study [19].
Fundus examination showed hypertensive retinopathy in one pa-
tient in our series, whereas it was seen in 25% of the patients in
Table 3
Maternal and fetal outcomes in previously reported case series.
Study No. of
patients
Total
pregnancies
Maternal complications Obstetric outcome
Hidaka et al, Japan (2012) [10] 10 26 Aortic regurgitation, 6; pregnancy-induced hypertension, 2 Spontaneous abortion, 6; MTP, 3; IUGR, 2
Mandal et al, India (2012) [9] 16 29 Gestational hypertension, 100%; pre-eclampsia, 92.85%;
PPH, 72.84%; CVA, 3.4%
IUGR, 51.72%; neonatal intensive care
admission, 58.62%
Hernandez-Pacheco et al,
Mexico (2011) [8]
7 7 Pre-eclampsia, 3 IUGR, 2
Suri et al, India (2010) [7] 15 37 Gestational hypertension, 27%; pre-eclampsia, 62%;
abruptio placentae, 2.7%; maternal death, 2.7%
IUGR, 16%; preterm delivery, 16%
Sharma et al, India (2000) [6] 12 24 Severe hypertension, 11; CHF, 2 Abortion, 2; IUD, 5; IUGR, 5; preterm, 4
Takeshi et al, Taiwan (1992) [5] 15 23 Hypertension, 13 MTP, 4 (active disease); IUGR, 6
Wong et al, China (1983) [4] 13 30 Hypertension, 14 IUGR, 9; abortion, 4
Ishikawa et al, Japan (1982) [3] 27 33 CVA, 1; severe hypertension, 6 Abortion, 1; IUGR, 5; preterm, 2
This study 12 18 Gestational hypertension, 5; pre-eclampsia, 2;
aortic & mitral regurgitation, 1; worsening of EF in DCMP, 1
Abortion, 5; IUD, 1; IUGR, 5; preterm, 1
CHF ¼ congestive heart failure; CVA ¼ cerebral vascular accident; DCMP ¼ dilated cardiomyopathy; EF ¼ ejection fraction; IUD ¼ intrauterine device; IUGR ¼ intrauterine
growth restriction; MTP ¼ massive transfusion protocol; PPH ¼ postpartum hemorrhage.
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patients in our series. One previous study reported renal asym-
metry in 50% of patients with Takayasu disease [20]. Doppler ex-
amination of vessels in our patients showed aortic involvement in
16.7% of patients and renal artery involvement in 25% of patients,
whereas in other study aortic and renal artery involvement was
seen in 91% and 75%, respectively [6]. The most common maternal
complication, as reported in prior studies, is severe pre-eclampsia
[3e10]. Other maternal complications associated with TA are
placental abruption, hypertensive retinopathy, intrapartum sub-
arachnoid/intracranial hemorrhage, aortic regurgitation, and
nephrotic syndrome. Gestational hypertension is themost common
maternal complication, seen in 27.8% of our patients. Mandal et al
[9] reported this condition in all patients they reported (N ¼ 29). In
other series, it ranges from 7% to 56.5% [4e11]. Pre-eclampsia also
has a higher prevalence in patients with TA than normal preg-
nancies. Although some have not reported pre-eclampsia in their
series, others have reported it to be seen in as high as 93% of pa-
tients [9]. It was seen in 5.6% of patients in our series. A prior study
suggests that administration of antihypertensives (methyldopa or
nifedipine) at early gestation improves maternal and fetal out-
comes [4]. Drugs used to control blood pressures in our patients
were alpha-methyldopa, labetalol, nifedipine, prazosin (adminis-
tered in the order presented). One patient in our series had been
diagnosed with dilated cardiomyopathy and she had worsening of
ejection fraction during pregnancy. Aortic and mitral regurgitation
has been reported earlier to complicate pregnancies with TA as
seen in this patient [10]. This patient had an otherwise favorable
outcome and the reason may be no renal involvement or reno-
vascular hypertension. Previous studies also reported other com-
plications such as cerebrovascular accidents, congestive heart
failure, abruption placentae, postpartum hemorrhage, and even
maternal death [7,9]. These complications were not seen in our
patients. The fetal complications associated with TA are abortions,
preterm deliveries, IUGR, and fetal demise. Spontaneous abortion
was seen in 27.7% of pregnancies in our series, whereas it was re-
ported to be 3e19% in various studies [3,6,10]. IUGR was seen in
27.7% of pregnancies in our series. It varied in the range of
7.7e51.7% in various studies [3e10]. Intrauterine fetal demise was
seen in one patient (5.5%) in our series; others have reported it to be
in 20.8% of cases [6]. Preterm delivery was reported in 5.5% of pa-
tients in our series. Others have reported it to range between 6%
and 16% [3,6,7]. Because of the high incidence of maternal and fetal
complications such as growth restriction and hypertension in
pregnancies with TA, requirement for induction of labor is more in
these patients (40% of our cases). The rate of cesarean section was28.5% in our patients, whereas some have reported it to be as high
as 57% [21]. In our series, the gestational age ranged between 29
weeks and 40 weeks and average birth weight was 2455 g. Another
study reported a gestational period ranging from 34 weeks to 40
weeks and the birth weight from 1425 g to 3024 g [21]. Throm-
boprophylaxis is recommended by some for patients with TA as
they might be associated with antiphospholipids antibodies,
especially those of Oriental origin [18,22,23]. We also used
thromboprophylaxis in two pregnancies. One had a favorable
outcome. The other patient with renal artery involvement without
intervention had severe fetal growth restriction despite thrombo-
prophylaxis treatment and eventual neonatal death. The cause of
poor obstetric outcome in this patient was severe renovascular
hypertension due to bilateral renal arterial involvement. Use of
low-molecular-weight heparin prolonged the duration of preg-
nancy as her previous demises were prior to 19 weeks of gestation.
The routine use of low-molecular-weight heparin prophylaxis in
these patients needs elucidation.
We observed that the patients in the higher Ishikawa group had
higher maternal and fetal complications as expected. It was also
observed that renal artery involvement led to poorer maternal and
fetal outcomes. We also observed that patients with renal artery
involvement, who had early interventions (angioplasty and stent-
ing), had a favorable outcome as compared with those with and
without any intervention for renal arterial involvement. The com-
plications in the intervention group are comparable to patients
without renal artery involvement. Delay in intervention can lead to
increased surgical risks and difﬁculties. Therefore, we recommend
that early intervention in TA patients with renal artery involve-
ment, when damage is not irreversible, is beneﬁcial.
In conclusion, young women diagnosed with TA need proper
preconceptional counseling. Planning of pregnancy during the
disease remission state is necessary to reduce maternal and fetal
risks. Early intervention prior to conception in women with renal
artery involvement is recommended to prevent complications in
pregnancy. Patients with renovascular involvement and subse-
quent hypertension are at high risk of having maternal and fetal
complications. Pregnancies with TA should be managed with a
multidisciplinary approach. Adequate blood pressure control in
pregnancy by judicious use of antihypertensives is the mainstay of
management. Role of low-molecular-weight heparin in pregnancy
with TA is controversial.
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